Surgical resection of the epileptogenic zone (EZ) is the most effective treatment for drug-resistant focal epilepsy. However, 30[ndash]80% of patients do not attain long-term seizure freedom post-surgery, indicating that pre-surgical evaluation often falls short of fully delineating the EZ. Accurate EZ-localization is challenging because each individual EZ is a unique and complex network, often comprising multiple overlapping neuropathologies. This hypothesis is supported by studies showing that combining multiple biomarkers enhances localization accuracy. Nonetheless, combining biomarkers leads to high-dimensional features that risks overfitting classifiers and reduces the interpretability of underlying neuropathology, ultimately limiting clinical applicability. We asked whether high-dimensional neuronal features could be reduced to a low-dimensional latent space to captures essential characteristics of the epileptogenic network (EpiNet). In the latent space, each sampled brain region is assigned an EpiNet-saliency score along a 0[ndash]1 continuum, characterizing the degree of epileptogenic proneness from lowest to highest. Using 10-minute interictal recordings from 7,183 stereo-EEG (SEEG) contacts across 64 focal epilepsy patients, we extracted 260 features of local and network dynamics. Singular value decomposition revealed that ten eigenfeatures were sufficient to identify brain regions where seizures emerged (SZ). These eigenfeatures were used to train two unsupervised classifiers, which converged on a consensus model for assessing EpiNet-saliency using only the first and second eigenfeatures, reducing the dimensionality to 0.77% of the original feature set. The resulting model was tested on 7[ndash]9 hours of sleep-SEEG recordings from three patients in an independent cohort and validated using tensor component analysis. Among the 64 training subjects, SZ-classification accuracy correlated with individual position in the eigenfeature space (r2=0.5), suggesting that variability in EpiNet-saliency contributes to differences in classification performance. The model was tested on three subjects from an independent cohort, where it successfully captured time-varying EpiNet-saliency in sleep-SEEG, corroborating clinical assessments and achieving peak classification accuracies of 0.63, 0.85, and 0.94, respectively. A separate tensor component analysis verified the spatiotemporal characteristics of model-predicted EpiNet-saliency in the sleep-SEEG. These results provide compelling evidence supporting our hypothesis of a low-dimensional representation of epileptogenicity, which appears to be independent of brain state or neuropathological origin. This innovative approach enables straightforward interpretation of neuropathology and facilitates the integration of additional biomarkers and study of large cohorts, owing to its minimal computational footprint. These advancements significantly enhance the feasibility of a framework for unified epilepsy biomarkers.